A groundbreaking discovery in the field of multiple sclerosis (MS) research has the potential to revolutionize our understanding of this complex disease. The future of MS treatment is here, and it's an exciting step towards a world without MS.
Australian scientists, led by Dr. Hamish King at WEHI, have made a significant breakthrough by tackling a long-standing gap in MS genetics. With a $2.8 million research grant from MS Australia, they aim to study over 100 genetic risk factors for MS collectively. This ambitious project promises to unlock the mysteries behind the development of MS and improve the lives of those affected.
But here's where it gets controversial: most of these genetic changes don't directly alter genes. Instead, they influence how genes are activated or deactivated within immune cells, making it challenging to pinpoint their exact role in the disease process.
Dr. King's team will now introduce and test these genetic risk factors in human immune cells, measuring their impact on gene activity and immune behavior. By understanding how these risk genes operate together, researchers hope to develop more precise treatments and improve long-term outcomes for MS patients.
Dr. King emphasizes, "We've known about these genetic markers for over two decades, but we've struggled to explain their impact on immune cell behavior. MS often arises from many small genetic differences acting in concert, and this platform will help us study those changes collectively and connect them to specific genes and pathways.
MS is an immune-mediated condition where the body mistakenly attacks the brain and spinal cord, damaging the protective myelin coating around nerve fibers. This can lead to mobility issues, vision problems, cognitive impairments, and reduced energy levels.
As the number of Australians living with MS continues to rise, with a 77.4% increase since 2010, the need for accelerated research is more urgent than ever. The total economic burden of the disease reached $3 billion in 2024, highlighting the impact of MS on individuals and society.
MS Australia's Head of Research, Dr. Tennille Luker, believes projects like Dr. King's are crucial in bridging the gap between genetic discovery and real-world impact. "Identifying risk is just the beginning. Understanding how these genetic changes drive the disease is key to changing its course."
Alongside this research, MS Australia is investing in projects that aim to slow disease progression, manage symptoms, and improve quality of life. These initiatives not only strengthen our current response to MS but also lay the scientific foundation for prevention and potential cures.
In addition to core funding, MS Australia has received generous support from the Browne Family, funding a Postdoctoral Fellowship awarded to Dr. James Hilton at the University of Melbourne. Dr. Hilton's work focuses on developing new compounds to protect nerve cells in progressive MS.
Over the past two decades, MS Australia has invested over $60 million in MS research, highlighting the importance of sustained national investment in this field.
CEO Rohan Greenland emphasizes, "Research gives hope to people living with MS, reminding them that progress is possible and better treatments and prevention are within reach. None of this would be possible without the dedication of our Member Organizations, donors, and the broader MS community. Together, we are accelerating the discoveries that bring us closer to a world without MS.
The research grants will be officially launched at Parliament House in Canberra on March 4th, at MS Australia's Advancing MS Research in Australia event. Speakers, including Dr. Monique Ryan MP and Ms. Renee Coffey MP, will highlight the importance of continued national commitment to MS research.
Here are some of the featured projects:
Sensory Shoe Insoles for Improved Balance in MS: Associate Professor Anna Hatton at The University of Queensland is developing sensory shoe insoles to enhance foot sensation and improve balance in MS patients. The goal is to reduce fall risk, support mobility, and boost independence and confidence.
Protecting Brain Blood Flow to Slow MS Progression: Professor Kaylene Young at the Menzies Institute for Medical Research, University of Tasmania, is investigating how changes in brain blood vessels may contribute to MS progression. Her team aims to identify drug targets that protect myelin and slow disability by examining genetic differences and their impact on blood flow, inflammation, and nerve cell survival.
Investigating Viral Triggers for MS: Mr. Alex Eisner at The Florey Institute of Neuroscience and Mental Health, the University of Melbourne, is examining how common viruses like Epstein-Barr may influence MS by studying associated antibody responses and epigenetic programming. This project aims to clarify the molecular mechanisms underlying viral infections and their impact on MS risk, progression, and treatment response.
Exploring Copper Disruption as a Key MS Risk Factor: Dr. Brittney Lins at Curtin University is investigating whether disrupted copper levels in the brain may connect major MS risk factors, including Epstein-Barr virus infection, vitamin D deficiency, and gut health. The project aims to identify new prevention and treatment strategies by examining the role of copper imbalance in myelin damage.
These projects showcase the diverse and innovative approaches being taken to tackle MS from various angles. By supporting and funding such research, MS Australia is leading the way towards a brighter future for those affected by this debilitating disease.
